Sopharma AD (WSE:SPH)
Poland flag Poland · Delayed Price · Currency is PLN
13.45
-1.45 (-9.73%)
Jun 17, 2025, 6:52 PM CET

Sopharma AD Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
2,4212,1012,0221,2941,304940
Upgrade
Market Cap Growth
-9.41%3.91%56.23%-0.77%38.76%1.01%
Upgrade
Enterprise Value
3,5742,9742,9232,0122,0841,869
Upgrade
Last Close Price
13.4512.2513.727.208.287.42
Upgrade
PE Ratio
12.7912.319.487.616.2113.50
Upgrade
PS Ratio
0.500.450.480.320.350.28
Upgrade
PB Ratio
1.281.131.210.760.840.71
Upgrade
P/TBV Ratio
1.901.701.340.830.960.84
Upgrade
P/FCF Ratio
6.7122.1544.095.96--
Upgrade
P/OCF Ratio
5.5712.5120.214.92--
Upgrade
EV/Sales Ratio
0.720.630.700.500.550.55
Upgrade
EV/EBITDA Ratio
9.4612.0110.297.079.4710.79
Upgrade
EV/EBIT Ratio
13.7917.7714.109.8014.4518.46
Upgrade
EV/FCF Ratio
9.9131.3563.749.27--
Upgrade
Debt / Equity Ratio
0.620.560.470.400.500.75
Upgrade
Debt / EBITDA Ratio
3.933.592.412.102.954.84
Upgrade
Debt / FCF Ratio
3.2611.1017.003.12--
Upgrade
Asset Turnover
1.271.291.371.361.321.20
Upgrade
Inventory Turnover
4.304.244.764.894.654.37
Upgrade
Quick Ratio
0.630.520.700.660.700.56
Upgrade
Current Ratio
1.241.171.291.411.351.12
Upgrade
Return on Equity (ROE)
11.17%10.28%13.59%11.10%14.97%4.43%
Upgrade
Return on Assets (ROA)
3.01%2.88%4.21%4.37%3.14%2.24%
Upgrade
Return on Capital (ROIC)
4.07%3.92%5.54%5.39%3.88%2.73%
Upgrade
Return on Capital Employed (ROCE)
7.50%7.10%10.30%10.10%7.90%6.20%
Upgrade
Earnings Yield
7.82%8.13%10.55%13.14%16.09%7.41%
Upgrade
FCF Yield
14.90%4.52%2.27%16.77%-17.32%-50.43%
Upgrade
Dividend Yield
2.70%-16.04%19.95%--
Upgrade
Payout Ratio
190.42%216.37%74.90%0.01%0.07%75.97%
Upgrade
Buyback Yield / Dilution
-24.34%-19.22%-10.64%0.36%0.31%0.11%
Upgrade
Total Shareholder Return
-21.64%-19.22%5.40%20.31%0.31%0.11%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.